As an Associate in the Healthcare vertical, Leah helps the team review and analyze prospective investment opportunities and present recommendations, focusing on the firm’s Identified Sector Opportunities (ISOs). She also collaborates with the Strategic Resource Group and portfolio company management to support existing investments through the next phase of growth.

Before joining the THL team, Leah worked at Guggenheim Securities as an Investment Banking Analyst in the BioPharma/Healthcare Group.  In her free time, she enjoys reading, theater and traveling.

Verticals
Healthcare (HC)
Verticals
Healthcare (HC)

Related content

2023 Healthcare Trends and Our Outlook for 2024
Insights
2023 Healthcare Trends and Our Outlook for 2024 

Operational Challenges, Patent Cliffs & Biotech Funding Slowdown, and Generative AI Define 2023; Encouraging Prospects Emerge for 2024 Key Takeaways: The healthcare industry experienced a significant transformation in 2023, driven by three defining trends: operational challenges due to staffing shortages and evolving payment models, looming patent cliffs for pharma manufacturers and a biotech funding slowdown that impacted

Healthcare (HC)
The Future of Pharmaceuticals: How Technology, Big Data, and AI May Help Speed Drug Development
Insights
The Future of Pharmaceuticals: How Technology, Big Data, and AI May Help Speed Drug Development 

A Recap of THL’s Pharma Technology Panel | Fall 2023 Key Takeaways: The pharmaceutical industry is undergoing a digital transformation driven by emerging technology, data proliferation, and artificial intelligence (AI). AI is playing a pivotal role in clinical trials by handling complex tasks and analyzing massive health data sets with speed and precision to ultimately improve the efficiency

Healthcare (HC)

Want to learn more?